Table 1.
Number of clinical trials conducted at the Medical Oncology Department with active recruitment of patients at any time during the study period.
| Study Year | Clinical Trials | |||||
|---|---|---|---|---|---|---|
| Total | Phase 0 n (%) |
Phase I and Basket n (%) |
Phase II n (%) |
Phase III n (%) |
Post-Authorization and Rollovers n (%) |
|
| 2010 | 140 | 0 | 37 (26.4) | 54 (38,6) | 49 (35.0) | 0 |
| 2011 | 161 | 0 | 48 (29.8) | 57 (35.4) | 56 (34.8) | 0 |
| 2012 | 219 | 0 | 66 (30.1) | 85 (38.8) | 68 (31.0) | 0 |
| 2013 | 232 | 0 | 75 (32.3) | 96 (41.4) | 61 (26.3) | 0 |
| 2014 | 251 | 0 | 83 (33.1) | 99 (39,4) | 64 (25.5) | 5 (2.0) |
| 2015 | 303 | 0 | 106 (35.0) | 94 (31.0) | 89 (29.4) | 14 (4.6) |
| 2016 | 370 | 0 | 129 (34.9) | 117 (31.6) | 108 (29.2) | 16 (4.3) |
| 2017 | 374 | 0 | 137 (36.6) | 107 (28.6) | 111 (29.7) | 19 (5.1) |
| 2018 | 421 | 0 | 161 (38.2) | 131 (31.1) | 107 (25.4) | 22 (5.2) |
| 2019 | 459 | 1 (0.2) | 162 (35.3) | 141 (30.7) | 121 (26.4) | 34 (7.4) |
| 2010–2019 | 2930 | 1 (0.03) | 1004 (34.3) | 981 (33.5) | 834 (28.5) | 110 (3.7) |